Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfatc3
|
ENSMUSG00000031902.9 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_106054301_106054489 | Nfatc3 | 4445 | 0.118574 | 0.45 | 5.2e-04 | Click! |
chr8_106075304_106075462 | Nfatc3 | 15750 | 0.104110 | -0.31 | 2.0e-02 | Click! |
chr8_106054637_106054799 | Nfatc3 | 4122 | 0.122209 | 0.30 | 2.5e-02 | Click! |
chr8_106058911_106059577 | Nfatc3 | 389 | 0.754831 | 0.25 | 7.1e-02 | Click! |
chr8_106059743_106060146 | Nfatc3 | 311 | 0.816766 | 0.10 | 4.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 17.04 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr1_170605499_170605914 | 16.42 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
15845 |
0.17 |
chr10_76642712_76643426 | 15.32 |
Col6a2 |
collagen, type VI, alpha 2 |
19439 |
0.14 |
chr19_53080891_53081464 | 13.19 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr18_35848127_35849279 | 9.65 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr12_89156413_89157009 | 9.41 |
Nrxn3 |
neurexin III |
36395 |
0.21 |
chr15_44462791_44462984 | 8.66 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
5334 |
0.19 |
chr17_47909349_47909983 | 8.51 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr14_76504101_76505194 | 8.19 |
Tsc22d1 |
TSC22 domain family, member 1 |
117 |
0.97 |
chr2_152636359_152637068 | 8.03 |
Rem1 |
rad and gem related GTP binding protein 1 |
3746 |
0.1 |
chr2_165884402_165885933 | 8.01 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr6_124919273_124920636 | 8.00 |
Ptms |
parathymosin |
149 |
0.88 |
chr3_100488535_100489982 | 7.87 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr3_103799140_103799457 | 7.68 |
Gm15471 |
predicted gene 15471 |
3831 |
0.09 |
chr1_152808152_152808403 | 7.46 |
Ncf2 |
neutrophil cytosolic factor 2 |
299 |
0.87 |
chr7_4739300_4740219 | 7.43 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr16_13276181_13276648 | 7.38 |
Mrtfb |
myocardin related transcription factor B |
11338 |
0.26 |
chr2_30463478_30464399 | 7.37 |
Ier5l |
immediate early response 5-like |
10281 |
0.13 |
chr6_30344055_30344206 | 7.30 |
Gm25625 |
predicted gene, 25625 |
3336 |
0.18 |
chr8_117089920_117090087 | 6.99 |
Bco1 |
beta-carotene oxygenase 1 |
5851 |
0.17 |
chr7_127768560_127769629 | 6.93 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr1_192823078_192823550 | 6.91 |
Gm38360 |
predicted gene, 38360 |
2187 |
0.22 |
chr5_14988977_14989543 | 6.90 |
Gm10354 |
predicted gene 10354 |
10325 |
0.21 |
chr7_27232781_27233338 | 6.89 |
Coq8b |
coenzyme Q8B |
36 |
0.93 |
chr8_124571772_124572095 | 6.78 |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
2227 |
0.26 |
chr1_130732805_130732969 | 6.78 |
AA986860 |
expressed sequence AA986860 |
777 |
0.43 |
chr5_103620346_103620572 | 6.73 |
Gm15844 |
predicted gene 15844 |
4012 |
0.16 |
chr14_14353319_14353777 | 6.62 |
Il3ra |
interleukin 3 receptor, alpha chain |
3927 |
0.13 |
chr6_5297603_5298489 | 6.60 |
Pon2 |
paraoxonase 2 |
284 |
0.91 |
chr17_29499759_29499915 | 6.54 |
Pim1 |
proviral integration site 1 |
6430 |
0.11 |
chr9_43261471_43261822 | 6.42 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
1766 |
0.31 |
chr2_153560652_153561518 | 6.37 |
Nol4l |
nucleolar protein 4-like |
31114 |
0.15 |
chr6_135364868_135365419 | 6.34 |
Emp1 |
epithelial membrane protein 1 |
2075 |
0.26 |
chr15_77214839_77215035 | 6.30 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
11501 |
0.15 |
chr6_4484046_4484465 | 6.18 |
Gm37883 |
predicted gene, 37883 |
57 |
0.97 |
chr1_34389196_34389610 | 6.16 |
Gm5266 |
predicted gene 5266 |
22032 |
0.09 |
chr14_69421207_69421358 | 6.14 |
Gm16867 |
predicted gene, 16867 |
5195 |
0.14 |
chr19_7551971_7552272 | 6.13 |
Plaat3 |
phospholipase A and acyltransferase 3 |
5338 |
0.17 |
chr1_162217277_162218166 | 6.12 |
Dnm3os |
dynamin 3, opposite strand |
2 |
0.57 |
chr4_144980888_144981094 | 6.12 |
Vps13d |
vacuolar protein sorting 13D |
2970 |
0.28 |
chr5_91292941_91293393 | 6.11 |
Gm19619 |
predicted gene, 19619 |
9746 |
0.24 |
chr3_152300472_152300771 | 6.07 |
Miga1 |
mitoguardin 1 |
2991 |
0.19 |
chr4_134395625_134396464 | 6.06 |
Pafah2 |
platelet-activating factor acetylhydrolase 2 |
276 |
0.86 |
chrX_123721926_123722462 | 6.04 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chr10_68090256_68090550 | 6.03 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
46223 |
0.13 |
chr6_117134651_117134802 | 6.01 |
Gm43930 |
predicted gene, 43930 |
9599 |
0.19 |
chr9_98805578_98805874 | 6.00 |
E330023G01Rik |
RIKEN cDNA E330023G01 gene |
14361 |
0.11 |
chr7_109191268_109192295 | 5.91 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr4_135002364_135002805 | 5.91 |
Syf2 |
SYF2 homolog, RNA splicing factor (S. cerevisiae) |
71574 |
0.08 |
chr1_134079049_134080074 | 5.90 |
Btg2 |
BTG anti-proliferation factor 2 |
441 |
0.75 |
chrX_123500550_123501093 | 5.85 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr14_120148889_120149119 | 5.84 |
Gm4681 |
predicted gene 4681 |
7375 |
0.22 |
chr16_45927578_45927797 | 5.83 |
Gm15640 |
predicted gene 15640 |
8636 |
0.17 |
chr11_117108668_117108878 | 5.82 |
Sec14l1 |
SEC14-like lipid binding 1 |
6395 |
0.11 |
chrX_123271195_123271712 | 5.80 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chr8_36283388_36283539 | 5.78 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
33947 |
0.16 |
chr2_28064287_28064444 | 5.73 |
Fcnb |
ficolin B |
20520 |
0.14 |
chr4_53139613_53139963 | 5.73 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
20107 |
0.2 |
chr10_76623290_76623874 | 5.72 |
Col6a2 |
collagen, type VI, alpha 2 |
48 |
0.97 |
chr5_137376317_137376507 | 5.72 |
Zan |
zonadhesin |
25326 |
0.08 |
chr2_163596427_163596638 | 5.71 |
Ttpal |
tocopherol (alpha) transfer protein-like |
5782 |
0.15 |
chr13_94328036_94328194 | 5.65 |
Gm5668 |
predicted gene 5668 |
28256 |
0.11 |
chr7_107567042_107567677 | 5.65 |
Olfml1 |
olfactomedin-like 1 |
87 |
0.96 |
chrX_42398787_42399138 | 5.63 |
Gm14619 |
predicted gene 14619 |
51450 |
0.15 |
chr1_135128257_135128434 | 5.62 |
Ptprv |
protein tyrosine phosphatase, receptor type, V |
83 |
0.94 |
chr1_192799944_192800186 | 5.60 |
Gm38360 |
predicted gene, 38360 |
21062 |
0.12 |
chr8_93180539_93180878 | 5.59 |
Ces1d |
carboxylesterase 1D |
5419 |
0.15 |
chr10_61920292_61920886 | 5.57 |
Gm5750 |
predicted gene 5750 |
39035 |
0.14 |
chr6_99520900_99522395 | 5.57 |
Foxp1 |
forkhead box P1 |
485 |
0.83 |
chr14_30870231_30870525 | 5.56 |
Stimate |
STIM activating enhancer |
134 |
0.94 |
chr17_3282000_3282199 | 5.53 |
Gm34035 |
predicted gene, 34035 |
1108 |
0.47 |
chr9_102643047_102643198 | 5.48 |
Anapc13 |
anaphase promoting complex subunit 13 |
14610 |
0.12 |
chr15_96973477_96973637 | 5.46 |
Slc38a4 |
solute carrier family 38, member 4 |
46394 |
0.16 |
chr11_85832197_85833021 | 5.44 |
Tbx2 |
T-box 2 |
58 |
0.84 |
chr2_62573777_62574179 | 5.44 |
Fap |
fibroblast activation protein |
2 |
0.98 |
chr14_120705317_120705468 | 5.40 |
Rpl19-ps5 |
ribosomal protein L19, pseudogene 5 |
7686 |
0.21 |
chr12_76673740_76674235 | 5.37 |
Sptb |
spectrin beta, erythrocytic |
36036 |
0.15 |
chr5_66082129_66082280 | 5.35 |
Rbm47 |
RNA binding motif protein 47 |
214 |
0.89 |
chr6_37400778_37401412 | 5.35 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
41051 |
0.19 |
chr1_162938415_162938748 | 5.35 |
Fmo6 |
flavin containing monooxygenase 6 |
1066 |
0.49 |
chr19_53852714_53853452 | 5.27 |
Rbm20 |
RNA binding motif protein 20 |
9873 |
0.15 |
chr16_97659183_97659376 | 5.26 |
Tmprss2 |
transmembrane protease, serine 2 |
48084 |
0.14 |
chr5_24855284_24855570 | 5.26 |
Rheb |
Ras homolog enriched in brain |
12803 |
0.14 |
chr6_88189509_88190427 | 5.24 |
Gm38708 |
predicted gene, 38708 |
713 |
0.56 |
chr10_120387024_120387466 | 5.23 |
9230105E05Rik |
RIKEN cDNA 9230105E05 gene |
2278 |
0.28 |
chr9_106318067_106318383 | 5.20 |
Poc1a |
POC1 centriolar protein A |
9503 |
0.13 |
chr10_95117161_95117554 | 5.17 |
Gm48868 |
predicted gene, 48868 |
978 |
0.52 |
chr5_139681780_139682442 | 5.16 |
Gm42424 |
predicted gene 42424 |
19536 |
0.16 |
chr2_102882991_102883200 | 5.16 |
Gm23731 |
predicted gene, 23731 |
14865 |
0.21 |
chr16_76680578_76680736 | 5.15 |
Gm45029 |
predicted gene 45029 |
144 |
0.97 |
chr4_83108431_83108582 | 5.14 |
Gm11248 |
predicted gene 11248 |
13035 |
0.19 |
chr2_121289033_121290183 | 5.07 |
Map1a |
microtubule-associated protein 1 A |
8 |
0.96 |
chr5_119807879_119808030 | 5.06 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
85 |
0.97 |
chr1_160037297_160037509 | 5.05 |
Gm37294 |
predicted gene, 37294 |
6928 |
0.17 |
chr9_113833592_113833892 | 5.04 |
Clasp2 |
CLIP associating protein 2 |
21142 |
0.2 |
chr17_26514334_26514507 | 5.03 |
Dusp1 |
dual specificity phosphatase 1 |
5901 |
0.11 |
chr5_146687980_146688258 | 5.02 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
18503 |
0.16 |
chr14_55824498_55825973 | 5.02 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
198 |
0.87 |
chr11_72388510_72388722 | 5.00 |
Mir6338 |
microRNA 6338 |
140 |
0.94 |
chr1_152593000_152593165 | 4.98 |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
323 |
0.92 |
chr1_167802317_167803268 | 4.98 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr13_109790264_109790416 | 4.98 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
33119 |
0.24 |
chr15_75593188_75593349 | 4.97 |
Gpihbp1 |
GPI-anchored HDL-binding protein 1 |
3360 |
0.15 |
chr17_80825502_80826283 | 4.94 |
C230072F16Rik |
RIKEN cDNA C230072F16 gene |
70901 |
0.1 |
chr18_13601014_13601364 | 4.92 |
AC103362.1 |
novel transcript |
211 |
0.97 |
chr7_120865040_120865504 | 4.90 |
Gm15774 |
predicted gene 15774 |
10026 |
0.13 |
chr12_111437603_111437970 | 4.90 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
4683 |
0.13 |
chr7_90063338_90063489 | 4.90 |
Gm44861 |
predicted gene 44861 |
20716 |
0.11 |
chr16_13205884_13206199 | 4.90 |
Mrtfb |
myocardin related transcription factor B |
50440 |
0.15 |
chr7_116286230_116286742 | 4.89 |
Gm44867 |
predicted gene 44867 |
3601 |
0.19 |
chr1_187155725_187155876 | 4.88 |
Spata17 |
spermatogenesis associated 17 |
12703 |
0.15 |
chr4_132489117_132489268 | 4.88 |
Gm12981 |
predicted gene 12981 |
20457 |
0.08 |
chr17_35047734_35047939 | 4.86 |
Msh5 |
mutS homolog 5 |
1091 |
0.16 |
chr5_102736197_102736419 | 4.85 |
Arhgap24 |
Rho GTPase activating protein 24 |
11335 |
0.3 |
chr3_89421048_89421425 | 4.84 |
Shc1 |
src homology 2 domain-containing transforming protein C1 |
392 |
0.65 |
chr4_135828546_135828880 | 4.82 |
Gm13000 |
predicted gene 13000 |
24965 |
0.1 |
chr16_10850443_10850829 | 4.82 |
Rmi2 |
RecQ mediated genome instability 2 |
15568 |
0.1 |
chr4_82249617_82249844 | 4.82 |
Gm5860 |
predicted gene 5860 |
183773 |
0.03 |
chr12_16870094_16870860 | 4.78 |
Gm36495 |
predicted gene, 36495 |
19596 |
0.13 |
chr10_116908685_116908852 | 4.77 |
Rab3ip |
RAB3A interacting protein |
11165 |
0.14 |
chr1_36588880_36589458 | 4.77 |
Fam178b |
family with sequence similarity 178, member B |
148 |
0.92 |
chrX_162967570_162967721 | 4.77 |
Ctps2 |
cytidine 5'-triphosphate synthase 2 |
1460 |
0.36 |
chr6_97463922_97464073 | 4.75 |
Frmd4b |
FERM domain containing 4B |
4711 |
0.23 |
chr19_10013816_10014234 | 4.75 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
991 |
0.4 |
chr3_85887352_85888077 | 4.70 |
4933425M03Rik |
RIKEN cDNA 4933425M03 gene |
23 |
0.56 |
chr1_64087943_64089121 | 4.69 |
Gm13748 |
predicted gene 13748 |
9878 |
0.19 |
chr11_48567924_48568075 | 4.69 |
Gm12180 |
predicted gene 12180 |
356 |
0.87 |
chr6_83032753_83034325 | 4.68 |
Dok1 |
docking protein 1 |
68 |
0.86 |
chr15_83565243_83565417 | 4.68 |
Tspo |
translocator protein |
1455 |
0.24 |
chrX_75372940_75373091 | 4.67 |
F8 |
coagulation factor VIII |
7026 |
0.13 |
chr7_143006404_143006665 | 4.66 |
Tspan32 |
tetraspanin 32 |
606 |
0.58 |
chr5_12233802_12233976 | 4.63 |
Gm42910 |
predicted gene 42910 |
88928 |
0.08 |
chr13_44451325_44451495 | 4.63 |
Gm27007 |
predicted gene, 27007 |
3893 |
0.18 |
chr16_15221271_15221422 | 4.63 |
Gm5404 |
predicted gene 5404 |
2502 |
0.3 |
chr8_105821377_105821718 | 4.63 |
Ranbp10 |
RAN binding protein 10 |
5658 |
0.1 |
chr18_8644320_8645204 | 4.62 |
Gm35232 |
predicted gene, 35232 |
34289 |
0.18 |
chr2_73002029_73002223 | 4.61 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
14885 |
0.14 |
chr7_133885149_133885300 | 4.61 |
Gm23631 |
predicted gene, 23631 |
54517 |
0.12 |
chr11_31830043_31830943 | 4.60 |
Gm12107 |
predicted gene 12107 |
2167 |
0.31 |
chr18_77819086_77819244 | 4.59 |
F830208F22Rik |
RIKEN cDNA F830208F22 gene |
22422 |
0.14 |
chr1_135794655_135795075 | 4.57 |
Tnni1 |
troponin I, skeletal, slow 1 |
4537 |
0.16 |
chr7_123420015_123420410 | 4.57 |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
2069 |
0.31 |
chr7_51913741_51914036 | 4.56 |
Gas2 |
growth arrest specific 2 |
12548 |
0.18 |
chr15_83215718_83216148 | 4.56 |
A4galt |
alpha 1,4-galactosyltransferase |
35796 |
0.09 |
chr1_23190480_23190843 | 4.56 |
Gm29506 |
predicted gene 29506 |
45012 |
0.12 |
chr2_158223549_158223754 | 4.55 |
D630003M21Rik |
RIKEN cDNA D630003M21 gene |
5571 |
0.15 |
chr11_99275984_99276135 | 4.54 |
Krt24 |
keratin 24 |
9203 |
0.12 |
chr2_152728271_152728504 | 4.49 |
Id1 |
inhibitor of DNA binding 1, HLH protein |
7864 |
0.11 |
chr3_103171228_103172264 | 4.49 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr5_147492662_147492929 | 4.48 |
Pan3 |
PAN3 poly(A) specific ribonuclease subunit |
24707 |
0.13 |
chr19_15941554_15941779 | 4.48 |
Gm3329 |
predicted gene 3329 |
1944 |
0.31 |
chr14_75837044_75838069 | 4.48 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr4_75329842_75330129 | 4.47 |
Gm11255 |
predicted gene 11255 |
5484 |
0.24 |
chr7_143305657_143306136 | 4.46 |
Gm37364 |
predicted gene, 37364 |
8198 |
0.14 |
chr2_156924623_156924803 | 4.46 |
Gm14278 |
predicted gene 14278 |
9330 |
0.1 |
chr2_16147962_16148326 | 4.45 |
Gm37416 |
predicted gene, 37416 |
124719 |
0.06 |
chr10_128149150_128149301 | 4.45 |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
5496 |
0.1 |
chr6_82030100_82030461 | 4.44 |
Eva1a |
eva-1 homolog A (C. elegans) |
10763 |
0.15 |
chr6_51172941_51173140 | 4.43 |
Mir148a |
microRNA 148a |
96870 |
0.07 |
chr14_22270040_22270215 | 4.43 |
Lrmda |
leucine rich melanocyte differentiation associated |
40038 |
0.21 |
chr13_23697544_23698095 | 4.42 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr11_67973337_67973488 | 4.42 |
Stx8 |
syntaxin 8 |
6906 |
0.17 |
chr1_106597920_106598310 | 4.42 |
Gm37053 |
predicted gene, 37053 |
8755 |
0.22 |
chr11_12291035_12291789 | 4.41 |
Gm12002 |
predicted gene 12002 |
23102 |
0.24 |
chr11_11879011_11879515 | 4.41 |
Ddc |
dopa decarboxylase |
1366 |
0.41 |
chr15_79893767_79894098 | 4.39 |
Apobec3 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
1091 |
0.35 |
chr10_4433482_4433825 | 4.38 |
Armt1 |
acidic residue methyltransferase 1 |
928 |
0.39 |
chr2_144159913_144160094 | 4.38 |
Gm5535 |
predicted gene 5535 |
14361 |
0.15 |
chr4_134514733_134514884 | 4.37 |
Aunip |
aurora kinase A and ninein interacting protein |
3809 |
0.13 |
chr6_149261092_149261243 | 4.36 |
Gm10388 |
predicted gene 10388 |
25606 |
0.13 |
chr2_166427069_166427341 | 4.36 |
5031425F14Rik |
RIKEN cDNA 5031425F14 gene |
20246 |
0.19 |
chr13_83344551_83344924 | 4.34 |
Gm48156 |
predicted gene, 48156 |
155028 |
0.04 |
chr8_25252569_25252996 | 4.34 |
Tacc1 |
transforming, acidic coiled-coil containing protein 1 |
3787 |
0.24 |
chrX_150903924_150904075 | 4.34 |
Gm8424 |
predicted gene 8424 |
22160 |
0.16 |
chr6_108457545_108458223 | 4.33 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
819 |
0.61 |
chr17_85941249_85941409 | 4.31 |
Gm30117 |
predicted gene, 30117 |
12750 |
0.26 |
chr5_30556400_30556600 | 4.31 |
Cib4 |
calcium and integrin binding family member 4 |
10664 |
0.12 |
chr13_112749249_112749523 | 4.29 |
Slc38a9 |
solute carrier family 38, member 9 |
13776 |
0.14 |
chr14_64193921_64194220 | 4.27 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
77756 |
0.08 |
chr17_29431602_29431753 | 4.26 |
Gm36199 |
predicted gene, 36199 |
1158 |
0.35 |
chr16_95708221_95708531 | 4.25 |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
2037 |
0.35 |
chr12_73223969_73224120 | 4.25 |
Trmt5 |
TRM5 tRNA methyltransferase 5 |
58627 |
0.1 |
chr2_139032247_139032491 | 4.24 |
Gm14067 |
predicted gene 14067 |
115437 |
0.06 |
chr1_170718316_170718467 | 4.23 |
Gm23523 |
predicted gene, 23523 |
33432 |
0.14 |
chr5_113626561_113626712 | 4.21 |
Cmklr1 |
chemokine-like receptor 1 |
979 |
0.52 |
chr7_98851335_98851712 | 4.20 |
Gm8398 |
predicted gene 8398 |
3572 |
0.18 |
chr10_37194543_37194694 | 4.19 |
5930403N24Rik |
RIKEN cDNA 5930403N24 gene |
53529 |
0.12 |
chr17_71251382_71251788 | 4.18 |
Emilin2 |
elastin microfibril interfacer 2 |
3821 |
0.19 |
chr16_17809524_17810128 | 4.17 |
Scarf2 |
scavenger receptor class F, member 2 |
5017 |
0.1 |
chr4_132515167_132515846 | 4.17 |
Sesn2 |
sestrin 2 |
5005 |
0.1 |
chr1_77141099_77141250 | 4.15 |
Gm25974 |
predicted gene, 25974 |
3579 |
0.28 |
chr1_181257261_181257857 | 4.15 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
15239 |
0.14 |
chr18_51239889_51240171 | 4.15 |
Gm25739 |
predicted gene, 25739 |
14245 |
0.3 |
chr12_83309035_83309329 | 4.14 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
14754 |
0.26 |
chr7_103812071_103812255 | 4.13 |
Hbb-bt |
hemoglobin, beta adult t chain |
1833 |
0.13 |
chr9_66277129_66277396 | 4.13 |
Dapk2 |
death-associated protein kinase 2 |
8888 |
0.23 |
chr9_118496084_118496263 | 4.13 |
Gm33460 |
predicted gene, 33460 |
7074 |
0.14 |
chr17_91551149_91551306 | 4.12 |
Gm49990 |
predicted gene, 49990 |
3108 |
0.21 |
chr17_12185970_12186143 | 4.11 |
Tdgf1-ps2 |
teratocarcinoma-derived growth factor, pseudogene 2 |
3865 |
0.23 |
chr7_140971780_140972116 | 4.11 |
Ifitm1 |
interferon induced transmembrane protein 1 |
3908 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 3.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
3.1 | 9.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
3.0 | 9.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.3 | 6.8 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
2.0 | 6.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.9 | 7.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.9 | 5.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 1.9 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.8 | 7.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.8 | 9.0 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
1.7 | 5.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.7 | 5.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.6 | 4.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.6 | 4.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.6 | 8.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.6 | 9.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.5 | 4.5 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.5 | 1.5 | GO:0070384 | Harderian gland development(GO:0070384) |
1.5 | 5.9 | GO:0018214 | protein carboxylation(GO:0018214) |
1.5 | 5.9 | GO:0060596 | mammary placode formation(GO:0060596) |
1.4 | 2.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.3 | 3.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.3 | 5.0 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.2 | 3.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.2 | 3.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.2 | 5.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.1 | 3.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
1.1 | 3.4 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.1 | 3.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.1 | 3.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.1 | 4.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.1 | 1.1 | GO:0003166 | bundle of His development(GO:0003166) |
1.1 | 4.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.1 | 4.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 3.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.0 | 2.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.0 | 2.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.0 | 3.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.0 | 3.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.0 | 5.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.0 | 5.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.0 | 3.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.0 | 4.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.0 | 3.8 | GO:0046909 | intermembrane transport(GO:0046909) |
0.9 | 8.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.9 | 3.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.9 | 2.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.9 | 0.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.9 | 2.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.9 | 2.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.9 | 2.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.9 | 2.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.8 | 2.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.8 | 0.8 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.8 | 6.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 2.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.8 | 1.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.8 | 2.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 3.9 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.8 | 3.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.8 | 3.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.8 | 3.1 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.8 | 3.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.8 | 2.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 1.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.8 | 2.3 | GO:0036394 | amylase secretion(GO:0036394) |
0.7 | 6.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.7 | 5.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.7 | 2.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.7 | 1.5 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.7 | 1.5 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) |
0.7 | 6.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.7 | 2.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.7 | 5.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.7 | 2.8 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 0.7 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) positive regulation of receptor catabolic process(GO:2000646) |
0.7 | 2.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 1.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.7 | 2.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 0.7 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.7 | 2.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.7 | 4.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.7 | 0.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.7 | 2.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 2.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 3.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 1.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.6 | 3.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 6.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 0.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.6 | 1.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 1.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.6 | 0.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.6 | 1.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.6 | 3.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 0.6 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.6 | 1.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.6 | 3.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.6 | 2.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.6 | 1.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.6 | 10.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 1.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 1.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.6 | 1.8 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.6 | 1.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.6 | 3.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 2.9 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.6 | 2.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.6 | 2.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 0.6 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.6 | 2.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 3.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 1.7 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.6 | 1.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 18.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.5 | 3.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.5 | 1.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.5 | 1.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 2.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.5 | 1.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 2.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 1.6 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.5 | 2.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 3.2 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.5 | 0.5 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.5 | 2.7 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.5 | 2.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 2.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 1.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.5 | 2.6 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.5 | 2.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.5 | 0.5 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.5 | 3.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 1.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.5 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.5 | 1.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 1.0 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.5 | 1.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.5 | 1.0 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 0.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 2.6 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.5 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 0.5 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.5 | 1.5 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.5 | 1.5 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.5 | 1.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 2.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 1.5 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.5 | 2.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 1.9 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.5 | 1.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.5 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 1.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.5 | 1.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.5 | 1.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 1.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 2.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 5.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.5 | 1.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 0.9 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.5 | 2.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 7.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.5 | 1.9 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 2.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 1.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 3.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 0.5 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.5 | 2.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 0.5 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.5 | 2.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.5 | 5.1 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.5 | 1.4 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.5 | 2.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.5 | 1.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 0.9 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 0.9 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.5 | 2.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.5 | 1.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 2.7 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 1.4 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.4 | 0.4 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.4 | 2.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 0.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.4 | 0.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 1.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 1.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 0.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.4 | 1.8 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 1.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.8 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.4 | 3.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 4.8 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.4 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 2.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.4 | 2.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.4 | 0.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.4 | 1.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 3.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 0.9 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.4 | 2.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 0.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.4 | 1.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 2.5 | GO:0090009 | primitive streak formation(GO:0090009) |
0.4 | 1.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 0.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 2.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 1.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 1.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 0.8 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.4 | 0.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.4 | 4.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 0.8 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.4 | 4.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.4 | 1.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.4 | 2.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 1.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 0.8 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 2.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 1.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.4 | 1.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.4 | 0.4 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.4 | 2.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.4 | 1.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 4.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 2.8 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.4 | 2.8 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 1.2 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 2.8 | GO:0034311 | diol metabolic process(GO:0034311) |
0.4 | 0.8 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 0.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.4 | 0.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.4 | 3.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 2.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 1.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 1.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.4 | 0.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.4 | 1.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 0.4 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.4 | 1.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 0.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 | 1.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 0.8 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.4 | 0.8 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.4 | 1.5 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 3.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.4 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 2.3 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 0.4 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.4 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 1.1 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.4 | 3.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.4 | 0.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.4 | 0.4 | GO:2000591 | cell migration involved in kidney development(GO:0035787) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 0.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 1.5 | GO:0009838 | abscission(GO:0009838) |
0.4 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 1.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 2.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.4 | 1.5 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 1.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 0.4 | GO:0003192 | mitral valve formation(GO:0003192) |
0.4 | 2.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.4 | 1.8 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 0.7 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.4 | 1.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 3.9 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 0.7 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.4 | 0.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.4 | 0.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.4 | 0.7 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.4 | 1.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 2.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 1.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 3.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 0.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 2.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 2.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 1.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 3.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 1.4 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 0.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 1.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 4.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 1.4 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.3 | 3.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 2.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 1.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 4.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 3.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 2.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 3.3 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.3 | 1.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 1.0 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 2.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 1.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 2.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 2.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 2.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 1.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 1.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 0.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 0.6 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.3 | 3.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 1.9 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.3 | 2.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 0.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.3 | 1.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.3 | 1.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 1.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 1.6 | GO:0008354 | germ cell migration(GO:0008354) |
0.3 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 1.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 1.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 2.5 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 0.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 1.6 | GO:0060430 | lung saccule development(GO:0060430) |
0.3 | 1.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 6.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 0.6 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.3 | 0.9 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 2.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 2.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 0.6 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 2.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 1.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 1.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 0.3 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.3 | 4.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.9 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 0.6 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.3 | 0.9 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 2.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 2.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 0.9 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 1.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 1.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 2.6 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.3 | 0.9 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 1.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 0.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 2.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.9 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.3 | 0.6 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 0.9 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.3 | 0.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 0.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.3 | 2.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 0.9 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 0.3 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.3 | 0.9 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 2.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 1.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 2.5 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 0.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 0.3 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.3 | 0.8 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.3 | 0.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.3 | 0.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.6 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 0.8 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.3 | 5.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 1.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 0.8 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 1.4 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.3 | 1.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.3 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.3 | 0.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 4.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 6.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 2.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 0.8 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.3 | 0.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 1.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 2.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.3 | 0.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 1.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.8 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.8 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 2.7 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.3 | 0.5 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.3 | 0.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.3 | 2.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 1.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 2.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 1.6 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.3 | 1.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 1.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 1.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 0.5 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.3 | 1.0 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.3 | 0.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 0.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.3 | 0.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 1.0 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.3 | 3.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.3 | 0.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.3 | 2.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.3 | 2.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.3 | 0.5 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 1.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 1.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 2.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.3 | 1.0 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.3 | 0.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.3 | 2.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 2.3 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.3 | 0.5 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.3 | 1.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 1.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.3 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.3 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.3 | 0.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.0 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.3 | 0.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 0.3 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 0.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 2.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 1.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 2.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 2.7 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 1.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 2.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 1.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 1.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 1.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 1.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.7 | GO:0031639 | plasminogen activation(GO:0031639) |
0.2 | 0.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.5 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.7 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 0.9 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.9 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 1.4 | GO:0010224 | response to UV-B(GO:0010224) |
0.2 | 0.7 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.5 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.2 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 2.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 1.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 3.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 4.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.5 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 2.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 2.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 1.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.2 | GO:0071827 | plasma lipoprotein particle organization(GO:0071827) |
0.2 | 0.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 1.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 3.2 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.7 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 1.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.7 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 1.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.7 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 0.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 2.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 2.6 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 1.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 2.2 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.2 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 2.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 2.8 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.2 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 3.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.2 | 0.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 4.4 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 0.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.2 | 0.4 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 1.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 1.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.2 | 3.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 1.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.2 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 3.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.4 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 4.1 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.2 | 1.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 1.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.2 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.2 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.6 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 1.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 1.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.2 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.2 | 0.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.2 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 0.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 1.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.6 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.6 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.6 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.8 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 2.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.6 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 1.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 1.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.8 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.2 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.2 | GO:1901256 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.2 | 0.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 1.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.4 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 1.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 0.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 0.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.4 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 2.2 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.2 | 5.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.4 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.2 | 0.6 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.2 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.2 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.2 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.2 | 0.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.4 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 1.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 0.7 | GO:0001556 | oocyte maturation(GO:0001556) |
0.2 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 1.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.5 | GO:0060026 | convergent extension(GO:0060026) |
0.2 | 1.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.5 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.2 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 2.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 1.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.7 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 0.9 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 1.8 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 0.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.3 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 1.5 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 0.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 1.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 0.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 1.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.5 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.2 | 1.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.2 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.2 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 5.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.2 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.2 | 2.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 1.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.8 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 1.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 1.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 1.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.5 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 2.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 1.8 | GO:0002385 | mucosal immune response(GO:0002385) |
0.2 | 0.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.2 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 0.5 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.2 | 0.5 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.2 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 1.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 1.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.2 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 1.0 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.8 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 0.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 1.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.6 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 0.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 1.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.5 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 0.5 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.2 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.3 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 0.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.6 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 3.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 1.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 2.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 1.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.3 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 1.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 1.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.1 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.1 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 1.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 2.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 1.3 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 4.2 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 1.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.9 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 1.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.4 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 1.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 2.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.3 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.4 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 1.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 2.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.4 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 3.9 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.3 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.1 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.1 | 0.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 2.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 1.0 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.4 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 2.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.4 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.1 | 0.5 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.3 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.4 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.5 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 1.3 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 1.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.9 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 1.2 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 1.1 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.9 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 7.8 | GO:0001890 | placenta development(GO:0001890) |
0.1 | 1.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.8 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.1 | 0.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.4 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 2.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 1.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.6 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 1.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 2.5 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.1 | GO:0036166 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) phenotypic switching(GO:0036166) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0016445 | somatic diversification of immune receptors(GO:0002200) somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.6 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:1903670 | regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 2.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 1.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 3.3 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 0.8 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.2 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 0.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 0.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.1 | 0.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 2.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 1.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.1 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.8 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.9 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 1.2 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 1.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 1.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.6 | GO:0022408 | negative regulation of cell-cell adhesion(GO:0022408) |
0.1 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.2 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.6 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 1.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.4 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.1 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.6 | GO:0015669 | gas transport(GO:0015669) carbon dioxide transport(GO:0015670) |
0.1 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.4 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) regulation of cGMP biosynthetic process(GO:0030826) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 1.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.7 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.1 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.7 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 1.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.1 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.1 | 1.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 1.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.5 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 0.7 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.5 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.6 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.1 | 0.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.6 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.6 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.1 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.1 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.5 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 2.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 1.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 2.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.4 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 2.6 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.4 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 1.0 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 1.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.3 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.5 | GO:1904407 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.1 | 0.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0032344 | aldosterone metabolic process(GO:0032341) regulation of aldosterone metabolic process(GO:0032344) |
0.1 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.3 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.4 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 1.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.3 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.6 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 1.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 1.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 1.7 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.4 | GO:0001889 | liver development(GO:0001889) |
0.1 | 0.3 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
0.1 | 0.1 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.1 | 0.3 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 6.2 | GO:0051236 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.1 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.2 | GO:1903441 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.2 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.1 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 0.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.1 | 0.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.5 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 3.0 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 2.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.4 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.6 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 1.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.7 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 2.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.9 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.5 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.5 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 2.1 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.1 | 0.4 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.1 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.2 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.1 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.3 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.6 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.1 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.1 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 1.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.1 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 0.7 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 1.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 1.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 1.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.1 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.3 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.4 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.5 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.8 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.1 | 0.1 | GO:0002761 | regulation of myeloid leukocyte differentiation(GO:0002761) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.1 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 1.2 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 1.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 2.8 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.4 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 1.1 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 1.5 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.1 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.1 | 0.7 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.1 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 1.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.4 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 4.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 1.2 | GO:0051250 | negative regulation of lymphocyte activation(GO:0051250) |
0.1 | 0.1 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) specification of axis polarity(GO:0065001) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.1 | 2.9 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.3 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.3 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.1 | 0.1 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 1.0 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.1 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 1.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 4.8 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.1 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.2 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.0 | 0.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.0 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.6 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.0 | 0.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.0 | 0.9 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.0 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.0 | 0.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.0 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.0 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.2 | GO:0034982 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.2 | GO:0035268 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 2.0 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.3 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.0 | 1.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.3 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.6 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 1.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.0 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.0 | 1.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 3.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.8 | GO:0072655 | establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.3 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 3.1 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.0 | 0.0 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0006775 | fat-soluble vitamin metabolic process(GO:0006775) |
0.0 | 0.1 | GO:0035745 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.1 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0070318 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.2 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.2 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 1.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0051280 | negative regulation of calcium ion transport into cytosol(GO:0010523) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 1.9 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.0 | GO:0002664 | regulation of T cell tolerance induction(GO:0002664) |
0.0 | 0.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 2.0 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.0 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.2 | GO:0072376 | protein activation cascade(GO:0072376) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.0 | 0.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0001910 | regulation of leukocyte mediated cytotoxicity(GO:0001910) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.0 | GO:1902884 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.0 | 0.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.0 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.5 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.1 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0010092 | specification of organ identity(GO:0010092) |
0.0 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.0 | 0.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.5 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 1.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.5 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.0 | GO:0030301 | cholesterol transport(GO:0030301) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.0 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.0 | 0.0 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.0 | 0.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 8.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.5 | 4.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.4 | 4.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.1 | 5.6 | GO:0008091 | spectrin(GO:0008091) |
1.1 | 7.7 | GO:0042382 | paraspeckles(GO:0042382) |
1.1 | 3.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.0 | 2.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.9 | 4.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 3.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 3.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 4.6 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.8 | 3.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 3.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.7 | 2.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.7 | 2.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 2.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 1.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 2.5 | GO:0000938 | GARP complex(GO:0000938) |
0.6 | 2.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 4.5 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 2.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 2.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 1.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 2.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 3.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 2.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 1.6 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 2.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 2.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.5 | 2.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 1.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 2.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 3.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 2.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 4.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 2.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 0.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 1.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 5.8 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 1.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 2.9 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 2.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 1.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 1.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 2.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 3.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 2.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 1.6 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 0.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 2.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.4 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.4 | 1.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 2.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 21.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 2.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 1.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 2.2 | GO:0005818 | aster(GO:0005818) |
0.4 | 1.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 1.4 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 1.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 1.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 1.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.3 | 1.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 1.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 1.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 2.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 3.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 4.8 | GO:0043034 | costamere(GO:0043034) |
0.3 | 1.6 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 2.8 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 3.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 2.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 2.2 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 4.0 | GO:0031430 | M band(GO:0031430) |
0.3 | 1.2 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 0.9 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 3.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 0.6 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 1.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 16.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 20.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 0.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 2.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 3.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 1.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 0.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 4.9 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 0.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 6.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 1.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.3 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 1.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 2.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 5.2 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 2.9 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 2.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 2.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 2.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 10.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 5.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 2.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 3.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.2 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 3.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.7 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 9.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.7 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 1.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.2 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 1.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 1.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 2.7 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 3.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 2.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 0.7 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 5.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 1.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 9.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 1.3 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 3.6 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 3.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 3.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 2.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 3.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.3 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 45.4 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.2 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.7 | GO:0031672 | A band(GO:0031672) |
0.2 | 3.1 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 1.1 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 2.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 3.6 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.2 | 1.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 2.7 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 2.8 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 1.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 11.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 2.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 1.4 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 1.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 0.5 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 6.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 3.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 2.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 5.5 | GO:0005844 | polysome(GO:0005844) |
0.2 | 3.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 2.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 1.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 15.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 5.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 5.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 4.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 8.7 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 7.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 3.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.1 | GO:0035748 | Scrib-APC-beta-catenin complex(GO:0034750) myelin sheath abaxonal region(GO:0035748) |
0.1 | 4.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 8.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 2.6 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 2.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 2.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 11.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 3.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 1.8 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 6.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 2.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 7.3 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 8.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 3.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 21.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 4.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 4.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.9 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 1.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 11.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 2.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 1.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.4 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 10.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.6 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 2.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 7.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 4.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 3.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 19.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.7 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 3.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.2 | GO:1990752 | microtubule minus-end(GO:0036449) microtubule end(GO:1990752) |
0.1 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 77.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.9 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.5 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 63.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 1.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 2.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 4.2 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.0 | GO:0000803 | sex chromosome(GO:0000803) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.1 | 8.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.0 | 5.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.6 | 4.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.4 | 4.3 | GO:0070538 | oleic acid binding(GO:0070538) |
1.4 | 4.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.4 | 4.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 1.3 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
1.1 | 5.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.1 | 3.3 | GO:0048030 | disaccharide binding(GO:0048030) |
1.1 | 7.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.1 | 4.2 | GO:0015265 | urea channel activity(GO:0015265) |
1.0 | 6.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.9 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.9 | 3.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.9 | 2.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.9 | 2.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.9 | 7.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.9 | 6.1 | GO:0018633 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.9 | 3.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.8 | 6.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 2.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 2.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 4.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.8 | 7.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.8 | 7.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.8 | 3.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 5.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.7 | 5.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.7 | 8.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 1.4 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.7 | 2.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.7 | 4.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 2.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.7 | 3.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 3.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.6 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 2.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 1.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 2.5 | GO:0035276 | ethanol binding(GO:0035276) |
0.6 | 1.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.6 | 7.4 | GO:0031005 | filamin binding(GO:0031005) |
0.6 | 1.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.6 | 3.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.6 | 1.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.6 | 2.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.6 | 1.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 4.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.6 | 2.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 1.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 4.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 1.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 1.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.6 | 2.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 2.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 2.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.6 | 1.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 1.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 2.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.6 | 1.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 1.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 2.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.5 | 5.3 | GO:0015250 | water channel activity(GO:0015250) |
0.5 | 3.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 2.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 1.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 4.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 1.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 2.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.5 | 1.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 2.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 1.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 7.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 3.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 2.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 3.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.5 | 3.5 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 1.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 5.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 2.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 3.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 1.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.5 | 1.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 7.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 4.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 1.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 2.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 1.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 1.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 1.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 1.8 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 4.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 4.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 1.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 6.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 1.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 1.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 1.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 0.8 | GO:0019825 | oxygen binding(GO:0019825) |
0.4 | 3.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 8.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 3.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 1.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 1.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 4.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 3.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 2.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 3.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 1.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 3.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 2.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 0.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 3.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 4.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 0.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.4 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 2.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 1.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 3.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 1.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.4 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.3 | 6.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 1.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.3 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 3.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 5.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 1.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 1.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 0.3 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.3 | 4.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 0.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 0.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 1.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 2.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 3.4 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 1.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.3 | 2.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 1.5 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 5.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 2.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 3.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 4.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 5.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 7.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 2.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.6 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 1.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 4.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 1.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 1.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 9.2 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 1.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 2.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 2.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 2.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 4.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 3.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 3.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 1.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 4.9 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 0.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 1.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 0.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 2.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.8 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 2.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 0.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 2.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 3.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 0.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 2.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 2.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 1.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.3 | 0.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 0.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 2.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 1.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 5.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 10.1 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 3.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 3.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 3.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 2.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.7 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 1.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 1.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 1.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 1.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 3.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 2.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.7 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 4.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 1.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.2 | 1.3 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 2.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 1.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 2.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.6 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 3.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 6.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 4.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 6.5 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 1.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 2.6 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 1.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 2.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 4.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 0.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 2.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 1.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 4.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 1.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 4.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 2.1 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 0.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 0.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 2.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 2.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 4.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 4.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 2.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 3.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 2.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 1.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 8.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 3.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 3.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 0.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 4.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 4.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 5.9 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 1.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 1.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 1.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 2.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 3.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 3.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 1.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 1.1 | GO:0034522 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.7 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 5.4 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 2.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 6.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.7 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.1 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.1 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 4.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.9 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 3.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 2.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.2 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.2 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 1.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 3.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 4.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.7 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 6.1 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.6 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 8.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.7 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.8 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.1 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 1.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.1 | GO:0001032 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 1.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 2.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 4.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 10.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.6 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 4.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 3.6 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 2.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 4.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 3.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 2.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 3.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 1.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 2.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.6 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 8.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 6.6 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.1 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 1.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 3.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 1.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 5.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 6.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 2.2 | GO:0018721 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 3.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.4 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 1.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 1.4 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 2.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.1 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 1.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 1.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.6 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 2.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0032767 | copper chaperone activity(GO:0016531) copper-dependent protein binding(GO:0032767) |
0.0 | 0.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 7.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 2.5 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 1.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 3.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.2 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 3.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 1.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 21.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.2 | GO:0035586 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) purinergic receptor activity(GO:0035586) |
0.0 | 0.0 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 2.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.0 | 5.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 1.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 2.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.1 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 3.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 17.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 19.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 18.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 8.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 6.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 12.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 12.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 2.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 2.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 9.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 11.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 6.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 12.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 3.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 6.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 2.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 14.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 4.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 11.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 4.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 4.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 3.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 3.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 3.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 1.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 6.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 1.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 2.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 2.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 9.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 9.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 9.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 6.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 2.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 2.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 7.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 3.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 2.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 3.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 5.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 1.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 5.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 2.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 5.3 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 4.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 5.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 4.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 3.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 3.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 13.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 2.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 12.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.2 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 2.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 1.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.8 | 3.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 9.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.8 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.8 | 8.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.7 | 6.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 6.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 5.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 7.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.6 | 6.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 8.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 5.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 0.5 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.5 | 7.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 12.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 4.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 4.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 2.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 3.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 8.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.4 | 1.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 5.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 0.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 5.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 5.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 5.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 17.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 8.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 9.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 7.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 5.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 11.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 5.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 9.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 5.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 3.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 2.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 5.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 5.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 2.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 6.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 8.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 2.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 2.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 2.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 1.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.3 | 2.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 2.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 2.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 4.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 5.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 5.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 5.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 5.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 6.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 3.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 4.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 5.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 3.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 6.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 0.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 3.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 13.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 13.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 2.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 0.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.2 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 11.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 3.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 1.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 0.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 1.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 1.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 3.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 1.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 1.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 1.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 1.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 12.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 3.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 5.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 4.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 5.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 12.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 1.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 2.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 2.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 1.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 3.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 3.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 2.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 2.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.0 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.7 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 3.9 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.5 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 1.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |